We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$130B
AUM Growth
+$9.49B
(+7.9%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
30.11%
Holding
293
New
14
Increased
69
Reduced
146
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alkermes
ALKS
|
+$447M |
| 2 |
United Airlines
UAL
|
+$312M |
| 3 |
Whirlpool
WHR
|
+$142M |
| 4 |
Mattel
MAT
|
+$127M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$143M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$135M |
| 3 |
Royal Caribbean
RCL
|
+$124M |
| 4 |
Microsoft
MSFT
|
+$107M |
| 5 |
AT&T
T
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.58% |
| 2 | Healthcare | 22.9% |
| 3 | Industrials | 16.95% |
| 4 | Consumer Discretionary | 9.45% |
| 5 | Financials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Charles River Laboratories
CRL
$11.3B
| $46.6M | 0.04% |
425,900
-300
| -0.1% | -$32.6K |
|
177
Tyson Foods
TSN
$20.7B
| $42.7M | 0.03% |
526,100
-5,000
| -0.9% | -$383K |
|
|
SREV
178
DELISTED
ServiceSource International, Inc.
SREV
| $41.1M | 0.03% |
13,287,533
+313,450
| +2% | +$1.01M |
|
|
MNTA
179
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $40M | 0.03% |
2,868,900
+30,000
| +1% | +$406K |
|
180
Norfolk Southern
NSC
$76.7B
| $39.8M | 0.03% |
275,000
| – | – |
|
181
GSK
GSK
$103B
| $38M | 0.03% |
858,028
-2,400
| -0.3% | -$111K |
|
|
SAVE
182
DELISTED
Spirit Airlines, Inc.
SAVE
| $36M | 0.03% |
801,700
-76,224
| -9% | -$2.93M |
|
183
Stryker
SYK
$129B
| $35.2M | 0.03% |
227,100
-400
| -0.2% | -$61K |
|
184
Nutanix
NTNX
$16.6B
| $34.8M | 0.03% |
985,732
+900
| +0.1% | +$27.3K |
|
185
Standard BioTools
LAB
$321M
| $34M | 0.03% |
5,775,143
| – | – |
|
|
ONC
186
BeOne Medicines Ltd
ONC
$33.5B
| $30M | 0.02% |
307,020
+15,015
| +5% | +$1.37M |
|
|
HA
187
DELISTED
Hawaiian Holdings, Inc.
HA
| $29.9M | 0.02% |
751,300
+110,000
| +17% | +$4.23M |
|
|
BBBY
188
DELISTED
Bed Bath & Beyond Inc
BBBY
| $27.2M | 0.02% |
1,238,150
-77,376
| -6% | -$1.68M |
|
189
Cerus
CERS
$441M
| $26.4M | 0.02% |
7,800,000
| – | – |
|
190
OSI Systems
OSIS
$3.9B
| $25.2M | 0.02% |
391,500
-32,800
| -8% | -$2.76M |
|
|
IMGN
191
DELISTED
Immunogen Inc
IMGN
| $24.5M | 0.02% |
3,823,300
| – | – |
|
|
ALTR
192
DELISTED
Altair Engineering Inc
ALTR
| $24.2M | 0.02% |
+1,012,400
| New | +$22.5M |
|
193
General Dynamics
GD
$104B
| $24M | 0.02% |
118,000
| – | – |
|
194
PepsiCo
PEP
$190B
| $24M | 0.02% |
200,000
| – | – |
|
195
OraSure Technologies
OSUR
$287M
| $23.9M | 0.02% |
1,266,000
+7,000
| +0.6% | +$127K |
|
196
NOV
NOV
$7.13B
| $23.8M | 0.02% |
661,641
-2,204
| -0.3% | -$74.6K |
|
197
Lowe's Companies
LOW
$122B
| $23M | 0.02% |
247,700
-623,500
| -72% | -$51.5M |
|
198
Accuray
ARAY
$37.2M
| $22.9M | 0.02% |
5,324,500
-8,000
| -0.2% | -$36.7K |
|
|
OMED
199
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $22.8M | 0.02% |
5,565,600
-300
| -0% | -$1.3K |
|
200
Celanese
CE
$4.96B
| $22.6M | 0.02% |
210,950
| – | – |
|
Similar funds
VAM
Primecap Management's Q4 2017 Portfolio in Review
As of Q4 2017, Primecap Management held 293 positions worth $130B, up 7.9% from $121B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2017 filing shows 14 new, 69 increased, 146 reduced and 7 closed positions. Its largest new stake was Ryanair: 1,297,500 shares worth $54.1M. The largest sale was NVIDIA, an estimated $143M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2017 buy was Ryanair: 1,297,500 shares worth $54.1M.
- Primecap Management added most to Alkermes in Q4 2017, an estimated $447M increase.
- Primecap Management's biggest Q4 2017 reduction was NVIDIA, cutting an estimated $143M.
- Primecap Management fully exited Potash Corp Of Saskatchewan in Q4 2017, selling an estimated $12.3M.
- Primecap Management's ten largest holdings make up 30% of its $130B portfolio in Q4 2017.
- Primecap Management opened 14 new positions and closed 7 in Q4 2017.
- Primecap Management's portfolio value rose 7.9% quarter-over-quarter to $130B.
Based on Primecap Management's 13F filing for Q4 2017, filed 13 Feb 2018.